Head of Evidence Generation - International Region

Ipsen Biopharmaceuticals Inc.; Paris; On-site; EUR 180,000 - 240,000; Full time

Job summary

Ipsen Pharma (SAS) is seeking a Head of Evidence Generation - International to lead the development and execution of the evidence generation strategy for IPSEN’s international markets (ex-US/Canada) across Oncology, Rare Diseases, and Neuroscience. The role focuses on high-quality clinical and real-world evidence to inform decisions, access, and patient outcomes.

You will provide strategic leadership for Phase IV, ISS, and RWE studies, build regional capabilities, and partner with medical, HEOR,

Qualifications

• Extensive experience in medical affairs, clinical research, RWE or HEOR within the pharmaceutical industry.
• Proven track record in leading regional or global evidence generation strategies.
• Experience with RWE, observational studies, and regulatory-grade data generation.
• Demonstrated strong leadership and design of Phase IV, pharmaco-epidemiology studies.

Responsibilities

• Develop and implement the International Evidence Generation Plan (IEGP) aligned with global medical strategies and local needs.
• Oversee planning, execution, and reporting of evidence generation projects across the region.
• Ensure scientific, ethical, and regulatory standards are met in all studies.
• Support country teams in project design and EGRB submission readiness.
• Collaborate with country medical directors, asset leads, market access, and HEOR to align with business objectives.
• Build RWE capabilities at local/regional level including operating models and trainings.

Skills

Medical affairs

Clinical research

RWE/HEOR

Leadership

Regulatory data

Education

Advanced degree in life sciences/medicine/epidemiology (MD/PhD preferred)

Job description

Title: Head of Evidence Generation - International Region

Company: Ipsen Pharma (SAS)

About Ipsen:

Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation.Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company's success. Join us on our journey towards sustainable growth, creating real impact on patients and society!For more information, visit us at https://www.ipsen.com/ and follow our latest news on LinkedIn and Instagram.

Job Description:

Are you ready to lead and innovate in a dynamic, patient-focused biopharmaceutical company? Ipsen is a growing global specialty-driven biopharmaceutical company focused on innovation and specialty care. We aim to make a sustainable difference by significantly improving patients' health and quality of life, providing effective therapeutic solutions for unmet medical needs through differentiated and innovative medicines in Oncology, Neurosciences, and Rare Diseases.

Why Ipsen?

• Patient-Focused: The patient is at the heart of everything we do, and improving their outcomes is the deliverable of every strategy.
• Employee Care: We care for our employees, who are the ambassadors making a real difference.
• Bold Leadership: We attract and develop bold, agile, entrepreneurial individuals who take full ownership of their decisions.
• Growth Opportunities: We offer a wealth of fulfilling challenges and growth opportunities in a fast-moving, game-changing organization.

About the Role:

The Head of Evidence Generation - International will lead the development and direction of the Ipsen International (EX US & Canada) evidence generation strategy (Phase IV, ISS, RWE) to support Ipsen's medical objectives across all therapeutic areas (Oncology, Rare diseases and Neurotoxins). This role is pivotal in shaping and delivering high-quality clinical and real-world evidence (RWE) that informs decision-making, supports access, and enhances patient outcomes. The role requires strong leadership, scientific rigor, and cross-functional collaboration to ensure alignment with global strategies and local market needs.

Key Responsibilities:

Strategic Leadership

• Responsible for developing strategies for evidence generation (Phase IV, ISS, RWE) at International that support healthcare clinical evidence gaps and the LCM of our products.
• Assess the local needs and build proposal for scaling RWE capabilities (HC, resources, operating model) at International countries.
• Define and implement the International Evidence Generation Plan (IEGP) in alignment with global medical strategies and local evidence needs.
• Provide budget input for activities related to Epidemiology and RWE studies and initiatives ensuring projects are adequately resourced.

Evidence Generation Execution

• Ensure that the Global IEGP is well implemented at local level and the country data gaps are well integrated in the IEGP (Global & Local) in alignment with lifecycle management (LCM) priorities.
• Oversee the planning, execution, and reporting of evidence generation projects (clinical studies, RWE, health outcomes research) across the region.
• Ensure scientific, ethical, and regulatory standards are met in all research activities.
• Support country teams in project design and EGRB submission readiness.

Cross-Functional Collaboration

• Partner with Country medical directors, asset medical leads, market access, clinical operations, and HEOR to align evidence generation with business objectives.

Capability Building

• Lead the development of RWE capabilities at the Local/regional level, including operating models, resources, and trainings.

External Engagement

• Identify key research opportunities, including clinical studies, real-world evidence projects, and health outcomes research and foster partnerships and collaborations with institutions at International.
• Proactively identify, evaluate, and secure access to high-quality external data sources.

Qualifications :

• Advanced degree in life sciences, medicine, epidemiology, or related field (MD, PharmD, PhD preferred).
• Extensive experience in medical affairs, clinical research, RWE or HEOR within the pharmaceutical industry.
• Proven track record in leading regional or global evidence generation strategies.
• Experience with RWE, observational studies, and regulatory-grade data generation.
• Demonstrated strong leadership and experience in designing and conducting Phase IV, pharmaco-epidemiology studies in support of p